Frontiers of anticoagulation therapy for atrial fibrillation

Slides:

Advertisements

Similar presentations

Non-invasive and invasive evaluation of aortic valve area in 100 patients with severe aortic valve stenosis: Comparison of cardiac computed tomography.

Advertisements

Dual-site right ventricular and left ventricular pacing in a patient with left ventricular systolic dysfunction and atrial fibrillation using a standard.

Acute myocardial infarction as presentation of an infiltrative lung neoplasia Aitor Uribarri, MD, Adolfo Villa, MD, Gerard Loughlin, MD, Francisco Fernández-Avilés,

The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.

Low atrial septal pacing with dual-chamber pacemakers reduces atrial fibrillation in sick sinus syndrome Hitoshi Minamiguchi, MD, Shinsuke Nanto, MD, PhD,

A case of cardiac sarcoidosis masquerading as arrhythmogenic right ventricular cardiomyopathy awaiting heart transplant Sahika Hisaoka, MD, Tomoko Sugiyama-Kato,

Prolonged survival after surgery for cardiac metastasis from malignant melanoma Antoine Noel, intern, Claire Toquet, MD, Jacques Dewilde, MD Journal of.

Radiofrequency catheter ablation of incessant atrial tachycardia in pregnant women with minimal radiation exposure: Lessons from two case studies Pil-Sung.

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

To Anticoagulate or not to Anticoagulate

Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC

Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation James A. Stone, MD,

Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated.

Volume 70, Issue 1, Pages (July 2017)

Volume 53, Issue 2, Pages (April 2009)

Volume 69, Issue 1, Pages (January 2017)

Volume 65, Issue 3, Pages (March 2015)

Volume 29, Issue 3, Pages (June 2013)

Subtherapeutic anticoagulation with dabigatran following Roux-en-Y gastric bypass surgery Daniel Lee, MD, Zachariah DeFilipp, MD, Kenneth Judson, DO,

Volume 55, Issue 3, Pages (May 2010)

Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention

Volume 28, Issue 6, Pages (December 2012)

Volume 64, Issue 3, Pages (September 2014)

Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.

Patients’ time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry Sean D. Pokorney, MD, MBA,

Volume 60, Issue 4, Pages (October 2012)

Volume 63, Issue 2, Pages (February 2014)

Functions of microRNA-33a/b and microRNA therapeutics

Role of the CHADS2 Score in Acute Coronary Syndromes

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Laurent Macle, MD, John Cairns, MD, Kori.

Oral Anticoagulant Therapy

Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control

Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation Lena Rivard, MD, MSc, Paul Khairy, MD,

Nat. Rev. Cardiol. doi: /nrcardio

Oral Anticoagulant Therapy

Volume 137, Issue 2, Pages (February 2010)

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation Pilar Gallego, MD, PhD, Vanessa Roldán,

Observers in the Medical Setting

Volume 13, Issue 1, Pages (January 2016)

Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD

Parinaz K. Ghaswalla, PhD, Spencer E

Colorectal cancer and atrial fibrillation: a case-control study

Perceived Complexity of Various Liver Resections: Results of a Survey of Experts with Development of a Complexity Score and Classification Major K. Lee,

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk? Peter J. Zimetbaum, MD, Amit Thosani, MD, Hsing-Ting Yu, MPH, Yan.

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin Keitaro Senoo, MD, Marco Proietti,

James R. Edgerton, MD, Cecile Mahoney, BS, Michael J

Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A

Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1

CHA2DS2-VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban W. Frank Peacock, MD, CAPT Sally.

Optimizing Atrial Fibrillation Management

Very long-term clinical outcomes after radiofrequency catheter ablation for atrial fibrillation: A large single-center experience Tetsuma Kawaji, Satoshi.

Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012 A.C.E.

Volume 16, Issue 1, Pages 3-9 (January 2019)

Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery Su-Kiat Chua, MD,

Dominick J. Angiolillo, MD, PhD Interventional Cardiology Clinics

Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study Walid Saliba, MD, MPH, Naomi.

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Maura Marcucci, MD, Gregory Y.H. Lip,

International Journal of Cardiology

Gavin C. Harewood, MD, FRCPI, MSc Gastrointestinal Endoscopy

Erratum Canadian Journal of Cardiology

Jeffrey Y. Lin, MD, Petar Igic, MD, FHRS, Kurt S

SAFETY AND EFFICACY OF DABIGATRAN COMPARED TO BRIDGED WARFARIN FOR PERIPROCEDURAL ANTICOAGULATION IN PATIENTS UNDERGOING RADIOFREQUENCY ABLATION FOR.

Thomas P. Moyer, PhD, Dennis J. O'Kane, PhD, Linnea M

Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation Finlay A. McAlister,

Commentary: Judgment day: Should you add atrial fibrillation ablation?

Figure 8. Stroke prevention strategy in patients with AF

Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events? D. George Wyse,

Presentation transcript:

Frontiers of anticoagulation therapy for atrial fibrillation Takeshi Yamashita, MD, PhD, FJCC Journal of Cardiology Volume 58, Issue 1, Pages 1-5 (July 2011) DOI: 10.1016/j.jjcc.2011.04.001 Copyright © 2011 Japanese College of Cardiology Terms and Conditions

Figure 1 A schema showing the complex pharmacology of warfarin and the simple pharmacology of new anticoagulants. VK, vitamin K; VKOR, vitamin K epoxide reductase; CYP, cytochrome P450. Journal of Cardiology 2011 58, 1-5DOI: (10.1016/j.jjcc.2011.04.001) Copyright © 2011 Japanese College of Cardiology Terms and Conditions

Figure 2 A comparison of strategy between CHADS2 score and CHA2DS2-VASc score. In both scoring systems, AF patients with 2 points or more are recommended for anticoagulation therapy. Most patients categorized into 1 point in CHADS2 score would move to 2 points in the new CHA2DS2-VASc score. Journal of Cardiology 2011 58, 1-5DOI: (10.1016/j.jjcc.2011.04.001) Copyright © 2011 Japanese College of Cardiology Terms and Conditions